Denali Therapeutics DNLI
Last Price
52 Week Range
$10.57 - $23.77
Next Earnings Date
Feb 26 2026
Next Earnings Date
Feb 26 2026
Last Price
DNLI Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Denali Therapeutics Inc. | 8-K | January 6, 2026 | |
Denali Therapeutics Inc. | 8-K | December 10, 2025 | |
Denali Therapeutics Inc. | 8-K | December 4, 2025 | |
Denali Therapeutics Inc. | 8-K | December 4, 2025 | |
Denali Therapeutics Inc. | 10-Q | November 6, 2025 | |
Denali Therapeutics Inc. | 8-K | November 6, 2025 | |
Denali Therapeutics Inc. | 8-K | October 14, 2025 | |
Denali Therapeutics Inc. | 10-Q | August 11, 2025 | |
Denali Therapeutics Inc. | 8-K | August 11, 2025 | |
Denali Therapeutics Inc. | 8-K | July 7, 2025 | |
Denali Therapeutics Inc. | 8-K | June 3, 2025 | |
Denali Therapeutics Inc. | 8-K | May 6, 2025 | |
Denali Therapeutics Inc. | 10-Q | May 6, 2025 | |
Denali Therapeutics Inc. | ARS | April 17, 2025 | |
Denali Therapeutics Inc. | DEF 14A | April 17, 2025 | |
Denali Therapeutics Inc. | DEFA14A | April 17, 2025 | |
Denali Therapeutics Inc. | 8-K | April 2, 2025 | |
Denali Therapeutics Inc. | 8-K | March 5, 2025 | |
Denali Therapeutics Inc. | 10-K | February 27, 2025 | |
Denali Therapeutics Inc. | S3ASR | February 27, 2025 | |
Denali Therapeutics Inc. | 8-K | February 27, 2025 | |
Denali Therapeutics Inc. | 8-K | January 13, 2025 | |
Denali Therapeutics Inc. | 8-K | January 7, 2025 | |
Denali Therapeutics Inc. | 8-K | November 18, 2024 | |
Denali Therapeutics Inc. | 8-K | November 6, 2024 | |
Denali Therapeutics Inc. | 10-Q | November 6, 2024 | |
Denali Therapeutics Inc. | 8-K | October 10, 2024 | |
Denali Therapeutics Inc. | 8-K | August 1, 2024 | |
Denali Therapeutics Inc. | 10-Q | August 1, 2024 | |
Denali Therapeutics Inc. | 8-K | May 31, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.